CompleGen, Inc. and Temple University School of Medicine Awarded NIH Grant to Study Effectiveness of Allosteric Inhibitors in Acute Lung Injury
Seattle, WA and Philadelphia, PA [September 17, 2012] Full Press Release
CompleGen Announces Successful Delivery of Its XenoGene Technology to Boehringer Ingelheim for Drug Discovery Under a Non-Exclusive Agreement.
Seattle, WA and Ridgefield, CT [January 17, 2012] Full Press Release
CompleGen, Inc. and DuPont Crop Protection Announce Research Agreement
Seattle, WA and Wilmington, DE [May 11, 2005] Full Press Release
CompleGen and DuPont Crop Protection Sign Agreement to Allow CompleGen Access to a Large Chemical Compound Library
Seattle, WA and Wilmington, DE [September 24, 2004] Full Press Release
CompleGen and Berlex Enter Into a Drug
Seattle [April 7, 2003] Full Press Release
CompleGen Awarded SBIR Grant to Discover
Novel Anti-Parasitic Drugs
Seattle [May 6, 2003] Full Press Release
CompleGen Announces Delivery of Targeted
Cell-Based Assays to DuPont Crop Protection
Seattle [March 27, 2003] Full Press Release
CompleGen receives SBIR award to discover
Seattle [March 1, 2002] Full Press Release
CompleGen and Berlex Biosciences begin
drug discovery collaboration.
Seattle [March 7, 2002] Full Press Release
CompleGen awarded SBIR grant to discover
novel anti-malaria drugs.
Seattle [March 15, 2002] Full Press Release